Maximal daily dose of pancreatic enzyme replacement therapy in infants with cystic fibrosis: A reconsideration

被引:32
作者
Borowitz, Drucy [1 ]
Gelfond, Daniel [1 ]
Maguiness, Karen [2 ]
Heubi, James E. [3 ,4 ]
Ramsey, Bonnie [5 ]
机构
[1] SUNY Buffalo, Sch Med & Biomed Sci, Women & Childrens Hosp Buffalo, Dept Pediat, Buffalo, NY 14222 USA
[2] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN USA
[3] Cincinnati Childrens Med Ctr, Cincinnati, OH 45229 USA
[4] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45221 USA
[5] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA
关键词
Pancreatic insufficiency; Pancreatic enzymes; Cystic fibrosis; Infant nutrition; INSUFFICIENCY; MANAGEMENT; NUTRITION; CHILDREN; GROWTH;
D O I
10.1016/j.jcf.2013.05.011
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The current recommendations for dosing of pancreatic enzyme replacement therapy (PERT) in infants with cystic fibrosis (CF) were made using a limited evidence base. The per meal recommended dose was extrapolated from dosing guidelines for older patients into a maximal daily dose for infants. We discuss why this maximal daily dose recommendation may be insufficient for young infants with CF, although the optimal dose of PERT for infants with CF remains unknown. (C) 2013 European Cystic Fibrosis Society. Published by Elsevier BAT. All rights reserved.
引用
收藏
页码:784 / 785
页数:2
相关论文
共 13 条
[1]   Monitoring growth, body composition, pubertal and bone status [J].
Borowitz, D ;
Baker, RD ;
Stallings, V .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2002, 35 (03) :246-259
[2]   Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis [J].
Borowitz, Drucy ;
Robinson, Karen A. ;
Rosenfeld, Margaret ;
Davis, Stephanie D. ;
Sabadosa, Kathryn A. ;
Spear, Stephanie L. ;
Michel, Suzanne H. ;
Parad, Richard B. ;
White, Terry B. ;
Farrell, Philip M. ;
Marshall, Bruce C. ;
Accurso, Frank J. .
JOURNAL OF PEDIATRICS, 2009, 155 (06) :S73-S93
[3]   PANCREATIC INSUFFICIENCY, GROWTH, AND NUTRITION IN INFANTS IDENTIFIED BY NEWBORN SCREENING AS HAVING CYSTIC-FIBROSIS [J].
BRONSTEIN, MN ;
SOKOL, RJ ;
ABMAN, SH ;
CHATFIELD, BA ;
HAMMOND, KB ;
HAMBIDGE, KM ;
STALL, CD ;
ACCURSO, FJ .
JOURNAL OF PEDIATRICS, 1992, 120 (04) :533-540
[4]  
*COMM SAF MED, 1995, REP PANCR ENZ WORK P
[5]  
Cystic Fibrosis Foundation Patient Registry, 2010, ANN REP CTR DIR
[6]  
Cystic Fibrosis Foundation Patient Registry, 2011, ANN REP CTR DIR
[7]   High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis [J].
FitzSimmons, SC ;
Burkhart, GA ;
Borowitz, D ;
Grand, RJ ;
Hammerstrom, T ;
Durie, PR ;
LloydStill, JD ;
Lowenfels, AB .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1283-1289
[8]  
Kalnins D, 1995, PEDIAT PULMON S, V20, P266
[9]  
Leonard C., 2005, PANCREATIC ENZYME RE
[10]  
Sinaasappel M, 2002, J Cyst Fibros, V1, P51, DOI 10.1016/S1569-1993(02)00032-2